YIMXELFA

Class [005]
Pharmaceutical preparations for the treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety and cognitive disorders, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely seizures; pharmaceutical preparations for the treatment of neuromuscular and central nervous system diseases and disorders, namely, brain, muscle, ocular motility and spinal cord infections, injuries and diseases; pharmaceutical preparations for the treatment of cranial and facial nerve disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely connective tissue injuries, diseases and disorders, bone and cartilage injuries, diseases and disorders; pharmaceutical preparations for the treatment of genitourinary diseases, namely, pelvic, urological and reproductive system diseases and disorders, and infections, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; pharmaceutical preparations for the treatment of autoimmune, cardiovascular, gastrointestinal, hematological, oncological, ophthalmological and respiratory system diseases and disorders; pharmaceutical preparations for the relief of allergies, hypertension, menopause diabetic neuropathy, and pain; antibiotics and anti-infectives, anti-inflammatories, anti-fungals, oral and injectable pharmaceutical contraceptives, human vaccines; pharmaceutical preparations for the treatment of viral skin infections, namely anti-virals; smoking cessation medications; pharmaceutical preparations for the treatment of renal disease and disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of muscular atrophy; pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycemia, gout, muscular dystrophy, sickle cell disease, and anemia. Pharmaceutical preparations for the treatment of alopecia areata, vitiligo, irritable bowel disease, ulcerative colitis, Crohn's disease and rheumatoid arthritis.